Complete Genome Sequence of a Multidrug-Resistant
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
Cephalosporins
/ pharmacology
Drug Resistance, Multiple, Bacterial
/ genetics
Humans
Klebsiella Infections
/ drug therapy
Klebsiella pneumoniae
/ genetics
Siderophores
Whole Genome Sequencing
beta-Lactamase Inhibitors
/ pharmacology
beta-Lactamases
/ genetics
beta-Lactams
/ pharmacology
cefiderocol
cross-resistance
β-lactam/β-lactamase inhibitor combinations
Journal
Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
entrez:
16
9
2022
pubmed:
17
9
2022
medline:
21
9
2022
Statut:
ppublish
Résumé
Carbapenemase-producing Enterobacterales (CPEs) strains represent a serious threat to public health. The rapid diffusion of CPEs is of particular concern due to the limited effective treatments available against these multidrug resistant microorganisms. In this study, we characterized the complete genome sequence of
Identifiants
pubmed: 36112395
doi: 10.1089/mdr.2022.0143
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
Cephalosporins
0
Siderophores
0
beta-Lactamase Inhibitors
0
beta-Lactams
0
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM